Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ANEB
ANEBULO PHARMACEUTICALS, INC.
OTC
$0.32
▼ DOWN 4.55% (-0.01)

KEY STATISTICS

Market Cap$12.85 M
52w High$2.85
52w Low$0.00
Dividend Yield—
Frequency—
P/E-1.66
Volume100
Shares Out.40.78M

COMPANY

LEADERSHIP

Richard Anthony Cunningham
CHIEF EXECUTIVE
Richard Anthony Cunningham

COMPENSATION 2026

Salary$131,400
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$385,408
Total$516,808

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 7, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
3

PRICE TARGET

Target High$6.00
Target Low$6.00
Target Median$6.00
Target Consensus$6.00

UPCOMING EARNINGS

DateSep 23, 2026
DayWednesday
Rev. Est.—
SEP
23
WED

PRICE

$0.32 ▼ DOWN 4.55% (−$0.01)
$0.30$0.31$0.32$0.339:33 AM9:43 AM9:52 AM10:02 AM10:12 AM10:21 AM10:31 AM0.32

About Anebulo Pharmaceuticals, Inc.

https://www.anebulo.com ↗

Anebulo Pharmaceuticals, a 2020-founded biotech in Lakeway, Texas, develops treatments like ANEB-001 for acute cannabinoid intoxication and substance addiction.

INDUSTRY

Biotechnology

A PRODUCT ANEBULO PHARMACEUTICALS, INC. IS KNOWN FOR

ANEB-001 (Selonabant)
ANEB-001 (Selonabant)

ANEB-001 (Selonabant) is a clinical-stage cannabinoid receptor antagonist developed to reverse acute cannabinoid intoxication, with a focus on an IV formulation for pediatric patients.

COMPETITORS

COMPETITOR
CRBP COMPARE
CRDL COMPARE
HRMY COMPARE
IXHL COMPARE
JAZZ COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 116.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
54.79%
HOLDERS
25
TOP 12 OF 25 · RANKED BY POSITION SIZE
22nw, LP
15.5M sh · $84.76M
Nantahala Capital Management, LLC
3.0M sh · $7.59M
Mangrove Partners
2.5M sh · $2.55M
Vanguard Group Inc
435.8K sh · $440.18K
Morgan Stanley
399.4K sh · $403.4K
Geode Capital Management, LLC
174.1K sh · $435.57K
Ikarian Capital, LLC
157.7K sh · $394.3K
Rangeley Capital, LLC
50.0K sh · $50.5K
Renaissance Technologies LLC
28.5K sh · $71.25K
Northern Trust Corp
24.4K sh · $60.98K
Citadel Advisors LLC
24.2K sh · $24.48K
Blackrock, Inc.
24.1K sh · $60.15K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score2

SECTORS PEERS

PEERPRICE
IMMX$13.94COMPARE
ZNTL$3.80COMPARE
WHWK$4.62COMPARE
MGNX$4.13COMPARE
COYA$4.59COMPARE
PLRX$1.11COMPARE
TLSA$1.01COMPARE
OKYO$1.67COMPARE